We have mapped the location in herpes simplex virus (HSV) DNA of (i) three mutations at different loci (syn loci) which alter the social behavior of infected cells from clumping of rounded cells to polykaryocytosis, (ii) a mutation which determines the accumulation of one major glycoprotein [VP8.0(C2)], and (iii) the sequences encoding four major virus glycoproteins [VP8.0(C2), VP7(B2), VP8.5(A), and VP19E(D2)]. The experimental design and results were as follows. (i) Analysis of HSV-1 x HSV-2 recombinants showed that the sequences encoding the VP19E(D2) glycoprotein map in the S component, whereas the sequences encoding the other three major glycoproteins are in two locations in the L component of HSV DNA. The templates specifying the HSV-1 and HSV-2 glycoprotein VP8.0(C2) appear not to be colinear; we isolated recombinants specifying glycoproteins comigrating in sodium dodecyl sulfate-polyacrylamide gels with VP8.0(C2) of both HSV-1 and HSV-2. (ii) Marker rescue of a ts mutant defective in accumulation of glycoprotein VP7(B2) showed that the mutation maps within a region containing the sequences encoding that glycoprotein. (iii)
We have mapped the location in herpes simplex virus (HSV) DNA of (i) three mutations at different loci (syn loci) which alter the social behavior of infected cells from clumping of rounded cells to polykaryocytosis, (ii) a mutation which determines the accumulation of one major glycoprotein [VP8.0(C2)], and (iii) the sequences encoding four major virus glycoproteins [VP8.0(C2), VP7(B2), VP8.5(A), and VP19E(D2)]. The experimental design and results were as follows. (i) Analysis of HSV-1 x HSV-2 recombinants showed that the sequences encoding the VP19E(D2) glycoprotein map in the S component, whereas the sequences encoding the other three major glycoproteins are in two locations in the L component of HSV DNA. The templates specifying the HSV-1 and HSV-2 glycoprotein VP8.0(C2) appear not to be colinear; we isolated recombinants specifying glycoproteins comigrating in sodium dodecyl sulfate-polyacrylamide gels with VP8.0(C2) of both HSV-1 and HSV-2. (ii) Marker rescue of a ts mutant defective in accumulation of glycoprotein VP7(B2) showed that the mutation maps within a region containing the sequences encoding that glycoprotein. (iii)
Marker transfer experiments involving transfection of rabbit skin cells with donor HSV-1(F) DNA and fragments from several donor strains causing fusion of Vero or both Vero and HEp-2 cells revealed the existence of three syn loci specifying the social behavior of cells and one locus (Cr) determining the accumulation of glycoprotein VP8.0(C2). The Cr locus maps to the right of the template specifying VP8.0(C2) glycoprotein. Loci syn 1 and syn 2 map at or near the Cr locus but can be segregated from it. Locus syn 3 maps at or near the template specifying glycoproteins VP7(B2) and VP8.5(A). The expression of mutations in the syn 1 and syn 3 loci appear to be cell type dependent, in that recombinants with these mutations fuse Vero cells but not HEp-2 cells. Recipients of the syn 2 locus or of both syn 2 and syn 1 loci fuse both Vero and HEp-2 cells.
Herpes simplex viruses 1 and 2 (human herpesviruses 1 and 2, HSV-1 and HSV-2) specify approximately 50 polypeptides in the course of their reproductive cycle (22, 34, 37, 41) . Recently, we reported the physical locations in HSV-1 and HSV-2 DNA of the templates specifying 26 viral polypeptides as determined by a combination of two techniques. The first involved analyses of HSV-1 x HSV-2 recombinants produced in cells doubly infected with both serotypes (36, 37 of HSV-2 DNA (32) . The features that enabled these studies were twofold. First, approximately 28 of the 44 (corresponding pairs of) polypeptides specified by these two viruses and characterized in this laboratory differed in electrophoretic mobility in sodium dodecyl sulfate (SDS)-polyacrylamide gels (37) . Second, although HSV-1 and HSV-2 DNAs have approximately the same size and a similar sequence arrangement and are closely related, they differ in the location of several restriction enzyme cleavage sites (30, 31, 36, 54, 60 ; G. S. Hayward, T. G. Buchman, and B. Roizman, unpublished data). Thus, both HSV-1 and HSV-2 DNAs consist of two covalently linked components, L and S ( Fig.  1) , each of which contains unique sequences bracketed by inverted repeats (47, 53, 57 KD HSV-2 virions consist of four populations that differ in the orientation of the L and S components relative to each other (9, 16, 47) . By comparing the segregation patterns of HSV-1 and HSV-2 polypeptides in lysates of cells infected by the recombinants with the corresponding HSV-1 and HSV-2 sequences in the recombinant DNAs, it was possible to assign a specific location to 26 polypeptide templates in parental DNAs (37) .
In this paper we report on the physical location in the viral DNA of the templates specifying the major viral glycoproteins and of mutations causing alterations in the social behavior of infected cells. Pertinent to these studies are the following:
(i) A characteristic of cells infected with most fresh isolates of HSV-1 is that they become rounded and clump. Variants and mutants differing in their effects on the interaction of infected cells among themselves have been reported. Thus, there are HSV-1 strains which cause cells to become rounded but not to clump (11) and strains that cause cells to fuse into polykaryocytes (7, 11, 14, 20, 59) . Within a given cell line, the nature of the interactions of cells among themselves is genetically determined by the virus (11, 44) . In earlier reports from this laboratory, this phenotypic expression of HSV-1 was described as the social behavior of infected cells (11, 29, 45) . In this report we refer to the genes determining the interaction of infected cells among themselves as the syn loci and have designated the two major manifestations of this J. VIROL. kP interaction, i.e., clumping of rounded cells and polykaryocytosis, as the syn+ and syn phenotype, respectively. We should note that the syn designation, although deeply ingrained and hence not easily changed, is both inaccurate and misleading inasmuch as syn+, which could be interpreted as cell fusion, in fact refers to the prevailing wild-type phenotype which causes clumping of rounded cells.
(ii) Most of the studies on the factors defining the social interactions between infected cells followed the discovery of mutants expressing the syn phenotype. Thus, early studies (44) concluded that HSV-1 alters the plasma membrane of infected cells so as to cause clumping or fusion because recruitment of cells into polykaryocytes or clumps required the interaction of plasma membranes of adjacent cells.
This conclusion was confirmed and extended in two series of experiments. The first demonstrated that infected cells acquire a new antigenic specificity. Thus, anti-infected cell serum and complement lysed 18-h infected cells but not 2-h infected cells (43, 50) . Subsequent studies on the cytolytic antibody showed that infected cells and virus share common antigens. Specifically, there was an excellent correlation between cytolytic and neutralizing titers in human convalescent and rabbit hyperimmune sera (50) . Moreover, adsorption of sera with partially purified virus removed cytolytic activity, whereas adsorption with purified membranes from infected cells removed neutralizing antibody (43, 49, 50) . As would be expected from these results, the second series of experiments demonstrated the incorporation of viral glycoproteins into cellular membranes during the replicative cycle (18, 19) . Moreover, viral glycoproteins in the plasma membrane could not be differentiated with respect to number and electrophoretic mobility from those present in the virion (24, 55) . The major glycoproteins present in the virion (17, 56) were designated as virion proteins VP7, VP8, VP8.5, and VP19E, and these correspond in the infected cell lysate to the fully glycosylated forms designated B2, C2, A, and D2 (55) . Inasmuch as we are concerned with the mapping of the templates specifying these glycoproteins by analysis of infected-cell polypeptides, the MATERIALS AND METHODS Viruses and cells. The pertinent properties of virus strains used in this study, i.e., HSV-1(F) (11) , HSV-1(MP) (20) , HSV-1(HFEM) PAAr (36) , HSV-1(03) (40), HSV-1(17) tsJ PAAr (5, 36), HSV-1(HFEM) tsN102 pAAr (36), HSV-1(KOS) tsE6 (2, 4, 51, 52), HSV-1(HFEM) tsLB2 (15, 32) , HSV-1(B2006) tk-(10), HSV-2(G) (11), HSV-2(GP6) (7) , and HSV-2(186) and HSV-2(186) tsB5 (42, 51, 52) (33) , and was used for marker rescue of the ts mutation. Preparation and titration of virus stocks on HEp-2 and Vero cells were done as described previously (11, 36) . The rabbit skin cells VOL. 29, 1979 680 RUYECHAN ET AL.
were originally obtained from J. McLaren.
HSV-1 x HSV-2 recombinants. The generation, isolation, DNA sequence arrangements, and the polypeptides specified by HSV-1 x HSV-2 recombinants used in this study have been described elsewhere (36, 
37).
Preparation of viral DNAs and restriction endonuclease fragments. Intact viral DNA was prepared either from virions (16) or by preparative centrifugation of infected cell lysates in Nal density gradients (58) . Purification of the restriction endonucleases was described elsewhere (5, 16, 36) . Digestion of viral DNA, preparative agarose gel electrophoresis, and isolation of individual restriction endonuclease fragments have been described elsewhere (6, 16, 36 (ii) Transfection of partial heteroduplexes. Approximately 0.5 Mug of an individual restriction endonuclease fragment generated by digestion of DNA isolated from a polykaryocyte-forming strain was mixed with 1.0 Mug of HSV-1(F) DNA purified from capsids isolated by extraction of the cytoplasm of infected cells. The DNA was denatured by the addition of 0.1 volume of 1 M NaOH; after 5 min at room temperature, the mixture was placed on ice and neutralized by the addition of 0.1 volume of 1 M KH2PO4. Then 5 M NaCl was added to give a final Na+ concentration of 1 M. The final volume of this reaction mixture was 1.0 ml. Annealing of the DNA was carried out for 18 to 20 h at 42°C. Samples were quenched in ice, sterile salmon sperm DNA was added to a final concentration of 15 yg/ml, and the mixtures were dialyzed against one change each of 0.01 M Tris-hydrochloride, 0.001 M EDTA, pH 7.4, and HEPESbuffered saline. After dialysis against 1 x HEPESbuffered saline, CaCl2 was added (to 0.13 M), and the transfection procedure described above was followed.
Cloning of recombinant viruses. Techniques used for cloning of recombinant viruses from Vero cells under soft agarose overlay medium were as described previously (36) . Recombinants F-(MP)A through F(MP)D were cloned on HEp-2 cells by the following method. HEp-2 cells were infected and maintained in medium 199-1% fetal calf serum containing 0.1% pooled human immunoglobulin G. After 48 h of incubation, the medium was removed, the cell monolayer was washed once with medium 199, and medium 199 containing 0.5% agarose was placed on the cells. After solidification of the agarose, the syncytial plaques were picked immediately as described (36 (37, 56) . Designation of recombinant viruses. The designations of the recombinants generated by crossing HSV-1 and HSV-2 viruses have been described elsewhere (36) . The recombinants generated by marker transfer were designated as follows. The first letter in the designation referred to the virus strain acting as the recipient. In most instances the recipient strain was HSV-1(F). The donor strains were indicated by the letters or a number in parentheses immediately after the recipient designation. The donor designations were H, MP, and 1061, referring to strains HSV-1(HFEM), HSV-1(MP) and HSV-1(1061), respectively. The final letter in the designation was used to differentiate individual clones for a given donor-recipient series.
Construction of HSV-1(1061 (36) . These viruses were cloned four times in this manner, and one resulting clone was designated HSV-1(1023). In the second cross, Vero cells were infected with HSV-1(1023) and HSV-1(B2006) tk-, a mutant lacking thymidine kinase, each at a multiplicity of PFU/cell. After 18 h of infection, the progeny was harvested, and polykaryocyte-forming recombinants resistant to PAA and thymine arabinoside were selected and cloned. One of the resulting clones was designed as HSV-1(1061).
RESULTS
(A) Mapping of viral glycoproteins by analysis of HSV-1 x HSV-2 recombinants: enumeration and comparison of the major HSV-1 and HSV-2 glycoproteins. Two sets of HSV-1 x HSV-2 intertypic recombinants were used for mapping of the major glycoproteins specified by HSV. The first set, consisting of 27 recombinants, was produced by doubly infecting cells with HSV-1 and HSV-2 mutants, and recombinants were selected as described by Morse et al. (36) . The phenotypes of the parental strains and recombinant progeny are listed in Table 1 . The recombinants were derived from four different crosses designated as series A, B, C, and D. The arrangements of HSV-1 and HSV-2 DNA sequences within the recombinants are shown in Fig. 2 .
The second set of recombinants, designated as the L series, was obtained by transfection of rabbit skin cells with mixtures of intact HSV-1(HFEM) tsLB2 DNA and the restriction endonuclease XbaI-I DNA fragment from HSV-2(G) DNA. This fragment is derived from map position 0.945 to 1.000 of HSV-2(G) DNA in the prototype arrangement (36) . The series L recombinants were selected from among the progeny of transfected cells and contain HSV-2 DNA sequences from 0.945 to 0.988 map units (32) . The phenotypes of the parental types and of the recombinants are shown in Table 1 .
A comparison of HSV-1 and HSV-2 glycoproteins specified by some of the parental strains is shown in Fig. 3 (22) , as updated by Morse et al. (37) .
The major glycoproteins were designated according to the nomenclature described by Spear (55) , with the exception that we designated both glycoproteins Di and D2 as D inasmuch as glycoprotein D1 appears to be a precursor of glycoprotein D2 (8, 55) .
The salient features of the results are as follows:
(i) The glycoproteins specified by both HSV-1 and HSV-2 varied intratypically in their apparent molecular weight. The variable glycoproteins are marked with a black dot in Fig. 3 . We have already noted intratypic variation among nonglycosylated polypeptides (40) , and this observation is consistent with earlier findings.
(ii) Glycoprotein A comigrated with infectedcell polypeptide 11, whereas glycoprotein D comigrated with infected-cell polypeptide 29. However, because different radiochemicals were used to label the infected-cell polypeptides and glycoproteins, comigation in polyacrylamide gels does not necessarily imply that the two polypeptides are equivalent. Corresponding infected-cell polypeptides could not be identified for glycoproteins C and B, either because the specific activity of the 14C-amino acid label is considerably lower than that of the D-[14C]glucosamine label, which would enhance detection of highly glycosylated polypeptides, or because only a small proportion of C and B polypeptides are glycosylated and the precursor polypeptides do not comigrate with the glycosylated products (19, 55) .
(iii) It is noteworthy that glycoprotein C was absent in cells infected with HSV-1(HFEM) tsN102 and maintained at the permissive temperature ( Fig. 3 ) and was either absent or undetected in cells infected with HSV-2(GP6) (Fig.  4) . Notwithstanding the absence of the C glycoprotein in these parental viruses, appropriate recombinants from crosses involving HSV-1(HFEM) tsN102 expressed a glycoprotein C characteristic of HSV-1, whereas recombinants from crosses involving HSV-2(GP6) expressed a glycoprotein C characteristic of HSV-2. The mutations in tsN102 and GP6 appear superficially similar to the Cr-mutation in HSV-1(MP) which, as described below, maps apart from the structural gene for glycoprotein C and appears to determine its synthesis.
Mapping of HSV glycoproteins. The physical locations of the glycoprotein templates in the HSV DNA were determined by comparing the segregation patterns of the HSV-1 and HSV-2 glycoproteins specified by the recombinant viruses with their DNA sequence arrangement as defined by restriction endonuclease cleavage sites. Cells infected with parental strains or with recombinant virus were labeled from 5 to 15 h VOL. 29, 1979 (Fig. 4 and 6 ). Cells infected The diagonal line spans the boundaries of the cross-HSV-l glycoproten C, sequences located beover sites as defined by the five restriction endonucle-tween 0.645 and 0.69 map units must encode the ase cleavage sites which define the boundaries of the HSV-2 glycoprotein C. Taken together, these crossover event. The hatch marks with a knob identify results lead to an immediate conclusion that the the restriction sites retained in recombinant DNA, structural genes of HSV-1 and HSV-2 glycoprowhereas those without knobs represent parental tein C are non-colinear. Accordingly, the obsercleavage sites that are absent in the recombinant vation that recombinants A6D, DlE4, and DlE5
DNA. The boxes on the map unit line represent the specified C glycoproteins characteristic of both reiterated sequence of L and S components of HSV HSV-1 and HSV-2 ( Fig. 4 and 6 cally separated on 9% SDS-polyacrylamide gels (B) Marker rescue of HSV-1(HFEM) tsB5. (Figs. 4-7) . The segregation patterns of the gly-Studies by Manservigi et al. (33) showed that coproteins are shown in Fig. 1 and are summa-cells infected with HSV-1(HFEM) tsB5 or with rized in Table 1 .
the recombinant HSV-1 (tsB5-MP5) and incu- Assays of the progeny virus from transfected cells were done in Vero or in both Vero and HEp-2 monolayer cultures. The fraction of progeny virus expressing the syn phenotype ( Fig. 8  and 9 ) for each of the donor fragments is shown in Table 3 . The results indicate that the genes determining the syn phenotype map in two locations. Moreover, comparison of titrations on Vero and HEp-2 monolayers of cloned progeny from the transfected cells (Table 4) indicated that HSV-1 DNA can contain at least three different mutations yielding the syn phenotype and that at least two mutations can be present in the same DNA without affecting the viability of the virus.
The basis for these conclusions and the salient features of the results are as follows:
(i) The donor fragment from HSV-1(MP) and HSV-1(03) DNAs which conferred the syn phenotype to recipient HSV-1(F) was derived from position 0.70 to 0.83 in HSV-1 DNA (Tables 3  and 4 ). The donor fragment of strain HSV-1(HFEM) which conferred the syn phenotype was derived from position 0.30 to 0. 42 (Tables 3  and 4) . As suggested by its construction, HSV-1(1061) yielded two fragments which conferred the syn phenotype to the recipient virus. The fragments arose from positions 0.70 to 0.83 and 0.30 to 0. 42 (Tables 3 and 4) .
(ii) Analyses of the progeny derived from transfections with intact HSV-1(F) DNA and fragments mapping between 0.70 and 0.83 map units indicated that this fragment may contain two independent syn loci conferring different syn phenotypes. Thus, the progeny derived from (Fig. 9 and Table 4 ). These recombinants, F(H)A, F(H)B, and F(H)C, are therefore phenotypically sinilar to the recombinants with mutations in the syn 1 locus obtained with HSV-1(03) and HSV-1(MP) DNA fragments. However, because this locus maps in a different position, we designated it as syn 3. Similar results were obtained with progeny from cells transfected with mixtures containing the HSV-1(1061) fragment derived from this position ( Fig. 9 and Table 4) .
Glycoproteins specified by marker transfer recombinants. The electrophoretic profiles of the glycoproteins in SDS-polyacrylamide gels for representative recombinants obtained from the transfection studies are shown in Fig. 10 . All of the parental strains and recombinant progeny specified polyproteins A and D, and no consistent pattern of variability has been observed. As a consequence, we shall not be concerned with them here. The results regarding glycoproteins B and C may be summarized as follows: b Fast-and slow-migrating forms of glycoprotein B are indicated by f and s; n, glycoprotein C was present and migrated normally in SDS-polyacrylamide gels; U, glycoprotein C and its precursor could not be detected; ND, not done. ' Uncloned progeny.
ation of glycoprotein C exists within the 0.70 to 0.83 map unit segment of the DNAs of HSV-1(MP) and of these recombinants. We have defined this locus as Cr+ in HSV-1(F) and Cr-in HSV-1(MP).
(ii) The syn 1, syn 2, and syn 3 loci appear to segregate from the Cr-locus. Thus, recombinants F(H)A through F(H)C are Cr+ syn 3, whereas F(MP)E through F(MP)F are Cr+ syn 1, as is the parental HSV-1(03) strain. The segregation of Cr-from syn 2 is apparent from the parental strain HSV-1(1061) and recombinants F(1061)A through F(1061)G, all of which are Cr+ syn 2 and possibly syn 1. (iii) The effect of mutations in the syn 1 and syn 2 loci on the synthesis and electrophoretic mobility of the glycoprotein B is not entirely clear. Thus HSV-1(03) containing a mutation in the syn 1 locus specified the fast-migrating form of B glycoprotein, whereas recombinants F(MP)E and F(MP)F with a mutation in the same locus specified the slow-migrating form of glycoprotein B. Similarly, the recombinants exhibiting the syn phenotype on both Vero and HEp-2 cells did not consistently produce a slowmoving glycoprotein B. The available data do not support the hypothesis that loci syn 1 and syn 2 affect the electrophoretic mobility of glycoprotein B.
(iv) Although glycoprotein B produced by HSV-1(HFEM) migrated more slowly than the glycoprotein specified by HSV-1(F), recombinants F(H)A, F(H)B, and F(H)C carrying a mutation in the syn 3 locus produced a fast-migrating glycoprotein characteristic of HSV-1(F).
DISCUSSION
Location of the glycoprotein genes on the physical map of HSV DNA. In this report we have presented the location of the major glycoprotein templates on the physical map of the HSV genome. As noted previously (36, 37) , the precision of the mapping by analyses of the DNAs and of infected-cell polypeptides specified by HSV-1 x HSV-2 recombinants hinges on the discrimination of the major HSV-1 and HSV-2 glycoproteins and on the number of crossover events in the recombinants. As indicated in this report and predicted from the studies of Cassai et al. (7), the major HSV-1 and HSV-2 glycoproteins can be differentiated on the basis of their electrophoretic mobility. Their map positions, defined by the crossover sites in the intertypic recombinants, are shown in Fig. 11 . The results are of interest from two points of view. First, the templates do not appear to be clustered. Thus, glycoprotein D maps in the S component, glycoprotein C maps to the right of the middle of the L component, and only glycoproteins B and A might be adjacent or in close proximity. The results suggest that these templates might not be transcribed from a common promoter site.
The second interesting aspect of the results is the observation that the templates specifying glycoprotein C of HSV-1 and HSV-2 are not colinear and the isolation of recombinants specifying glycosylated polypeptides which comigrate with both HSV-1 and HSV-2 glycoprotein C. These findings have three implications. First, non-colinearity of essential genes within a narrow region of the genome could preclude isolation of viable recombinants with crossover events in that region. Specifically, recombination between HSV-1 strains with non-colinear glycoprotein C genes could result in progeny (ii) the mutated loci specifying cell fusion can be segregated from the locus determining the accumulation of C glycoprotein; and (iii) the locus determining the accumulation of C glycoprotein in HSV-1(MP) appears to map to the right of the sequences encoding the C2 glycoprotein.
Our understanding of the nature of the Cr locus is not complete, but two comments should be made. First, we have not isolated Cr-recombinants that did not express a syn mutation because none of the progeny expressing the syn+ phenotype were tested for the production of the glycoprotein C. In principle, it should be possible to select Cr-mutants by cloning progeny of infected cells that do not react with antiserum to glycoprotein C in cytotoxic tests, but to our knowledge this has not been done. Second, the observation that spontaneous [e.g., HSV-1 (MP)] and mutagen-induced [e.g., HSV-1(13VB4)] mutants express the Cr-syn phenotype suggests a possible relationship between these loci. Among the many possible explanations it is conceivable that the sequences coding for the C glycoprotein, the Cr locus, and the syn 2 locus are within a transcriptional unit or even in partially overlapping templates. Much finer genetic mapping will be required to discriminate among the many possible explanations.
Mapping of the loci determining the social behavior of infected cells and the relationship ofthese loci to the structural genes specifying the major viral glycoproteins. In this study we have specifically focused on mutants and recombinants which alter the social interaction of cells from clumping of rounded cells (syn+) to polykaryocytosis (syn). We have presented data showing that HSV DNA contains at least three loci determining the nature of the interaction of infected cells among themselves and that mutations in these loci, singly or in combination, do not affect the viability of the virus. Several aspects of the results merit discussion:
(i) The results of the studies presented in this report ( Fig. 11) clearly indicate that the syn 1 and syn 2 loci do not map in the position of the structural genes of any of the major glycoproteins (A, B, C, and D). Inasmuch as these mutations must be in a function expressed at the plasma membrane, these mutations could be in minor glycoproteins that have not yet been characterized, in nonglycosylated membrane proteins, in an enzyme which specifically interacts with membrane proteins, or in an enzyme which specifically interacts with membrane proteins (e.g., a protease, glycosyltransferase, protein kinase, etc.).
(ii) The syn 3 locus maps within the boundaries assigned to the structural genes specifying the A and B glycoproteins (Fig. 11) . We cannot determine at this time whether the syn 3 locus is within the templates specifying these glycoproteins or in templates of other, as yet unmapped, polypeptides, but several observations should be noted. First, the available data have clearly established that glycoprotein B plays a significant role in promoting cell fusion inasmuch as at nonpermissive temperatures cells infected with HSV-1(HFEM) tsB5 make enveloped nucleocapsids but fail to accumulate glycoprotein B and do not fuse cells (33; M. Sarmiento and P. G. Spear, submitted for publication). The evidence accumulated by P. G. Spear and associates suggests that glycoprotein B is required for the fusion of the viral envelopes with the plasma membranes of uninfected cells. Second, the syn 3 locus mapped in this study may not lie within the same gene as the HSVl(HFEM) tsB5 mutation. This possibility is raised by the observations that the syn 3 mutation is present in the parental strain [HSV-1(HFEM)] and is expressed by the tsB5 mutant at the permissive temperature. Moreover, recombinants in the F(H) series that express the syn 3 mutation of HSV-1(HFEM) specify a gly-J. VIROL. coprotein B characteristic of the recipient HSV-1 (F) virus rather than that of the HSV-1(HFEM) donor. Attempts to segregate the syn 3 locus from the tsB5 mutation by genetic crosses of HSV-1(HFEM) tsB5 with another ts mutant specifying the syn+ phenotype have failed because the syn phenotype in both parent [HSV-1(HFEM)] and mutant [HSV-1(HFEM) tsB5] appears to be temperature sensitive at 38.5°C. Lastly, the supposition that the glycoprotein A template may contain a syn locus rests only on the observation that in a single recombinant (A7D) the replacement of HSV-1 glycoprotein A by the heterologous HSV-2 glycoprotein A resulted in the conversion of syn+ to syn phenotype. The exact location of the syn 3 locus within the 0.30 to 0.42 map unit boundaries is therefore uncertain; if the syn 3 locus does not map within the template specifying glycoprotein B, there is at least one additional syn locus (i.e., syn 4) mapping within the boundaries of the B glycoprotein template, as exemplified by HSV-1(HFEM) tsB5.
Physiology and factors regulating the social behavior of infected cells. Several comments should be made concerning the physiology and significance of the syn mutations.
(i) A major and perhaps unique characteristic of herpesviruses is that they are able to persist and cause recrudescences of lesions characterized by foci of cells actively producing virus in individuals exhibiting antibody in their sera. On the basis of these observations, it has been postulated that the ability of the virus to form such foci in the presence of antibody is the consequence of a cell-to-cell spread by direct extension and without being exposed to the extracellular fluid (3, 20, 21) . Indeed, herpes simplex viruses spread efficiently by direct extension, as evidenced by the fact that all plaque assays done in this laboratory are under a liquid overlay containing antibody and the titers obtained in this fashion are comparable with those obtained in assays employing more conventional overlays (21, 48) . Although virus variants carrying the syn mutations are able to spread better from cell to cell in the presence of antibody (20, 21, 39) and therefore could have a selective advantage in individuals carrying the virus and exhibiting high titers of neutralizing antibody in their serum, isolates carrying such mutations are rarely found. A necessary conclusio"n is that syn mutations might well be deleterious in the natural host even though, as noted earlier in the text, recombinants carrying one or more syn loci are viable.
(ii) Attempts to relate recruitment of cells into polykaryocytes to viral functions necessary for viral replication present an interesting puzzle that has not been resolved. Briefly, as noted in a previous report (44) , the recruitment of cells into polykaryocytes could be viewed as occurring in two steps. The first would cause tight adhesion of the membranes of adjacent cells, resulting in the formation of cell aggregates designated as propolykaryocytes. The second would involve fusion of the membranes and the formation of expanding channels across the membranes by lateral movement of fused membrane constituents. A similar series of events is discernible in the entry of herpesviruses into infected cells. Thus, the step of virus adsorption can be segregated from entry into the cells (25) , particularly with HSV-1(HFEM) tsB5 virions made at the nonpermissive temperature which adsorb but cannot penetrate and infect cells (M. Sarmiento and P. G. Spear, submitted for publication). Several reports have provided evidence that the entry of herpesviruses into the cell is effected by fusion of the envelope with the plasma membrane (7, 26, 27, 35 ; M. Sarmiento, M. Haffey, and P. G. Spear, submitted for publication). The puzzle stems from the observation that the prevailing wild-type virus carries out both steps during entry into the cell (adsorption followed by fusion of the envelope with the plasma membrane) but only the first step in the interaction of cells among themselves. Although to date we have not been able to discern any differences between virion envelope glycoproteins and those incorporated into the plasma membranes of infected cells, they may differ either in the extent to which they are modified by processing or in the nature of their aggregation.
(iii) In this study we have identified three loci specifying the nature of the social behavior of infected cells. The expression of two of the loci i.e., syn 1 and syn 3, appears to be cell type specific. The cell type dependence of the syn 2 locus is not clear inasmuch as it is possible that all recombinants exhibiting mutations in the syn 2 locus may also contain a mutation in the syn 1 locus. If the latter is the case, it is conceivable that the mutation in the syn 2 locus causes fusion of HEp-2 cells but not of Vero cells. A syn mutant (7) of HSV-2(G), designated HSV-2(GP6), does in fact cause polykaryocyte-containing plaques in HEp-2 cells but not in Vero cells, and therefore mutations exhibiting this phenotype could conceivably exist in HSV-1 as well. The three syn loci identified here are probably a minimal estimate because, as noted above, syn 3 may map in a different structural gene from that containing the HSV-1(HFEM) tsB5 mutation. The multiplicity of cell type-dependent syn loci scattered in apparently diverse VOL. 29, 1979 structural genes suggests that the gene products act as an aggregate and that mutations in any gene product can alter the nature of the aggregate, possibly as a consequence of cell-specific processing or cell-specific receptors. The identities of the gene products other than glycoprotein B in the putative aggregate are unknown. The role of glycoprotein C is uncertain; although in some instances the absence of glycoprotein C appears to correlate with the ability to form polykaryocytes, suggesting that glycoprotein C acts as an inhibitor (33, 46) , the isolation of recombinants F(1061)A through F(1061)E which express glycoprotein C and fuse HEp-2 cells appears to negate this conclusion. The proof that glycoprotein C inhibits fusion hinges on the demonstration that in this series of recombinants the glycoprotein C is mutated and cannot modify the function of glycoprotein B.
